Tendie Bot

Tendie.bot

Login
MRNA Articles
reddit/

Moderna's Wild Ride: Cancer Vaccine Rally Sparks Reddit Panic as Stock Pulls Back

Moderna (MRNA) dominated retail investor discussions on August 20 after a historic rally on cancer vaccine news triggered a sharp pullback. Reddit posts from r/wallstreetbets, r/smallstreetbets, and r/Shortsqueeze capture the emotional whiplash as traders weigh the biotech's long-term potential against short-term volatility.

  1. MRNA surged 176% after Moderna and Merck announced positive Phase 3 results for intismeran, an mRNA cancer therapy.

  2. The stock then pulled back sharply, causing panic among retail investors who bought near the peak.

  3. Reddit traders are comparing the setup to other biotech plays, with some eyeing SLS as a potential follow-up.

Moderna (

MRNA
$MRNA) became the center of retail investor attention on August 20, a day after the biotech stock staged a jaw-dropping 176% rally on positive cancer vaccine data. But the euphoria was short-lived. By the time the dust settled, the stock had given back a significant portion of those gains, leaving a trail of panicked posts across Reddit.

The catalyst was a joint announcement from Moderna and Merck on August 19. The companies revealed that their mRNA-based cancer therapy, intismeran, met the primary endpoint of recurrence-free survival in a Phase 3 trial for melanoma patients when combined with Merck's Keytruda. The experimental treatment is designed to activate anti-tumor immune responses, and the companies plan to seek regulatory approval. Analysts see a potential $275 billion global oncology market by 2030, and Moderna's stock briefly soared on the news.

But the pullback hit hard. On r/wallstreetbets, one investor posted in a panic: "I was stupid and bought in around $160 and now it’s tanking and I already lost ~$800 do I hold or what do I do. PANICING." The post drew 69 upvotes and 213 comments, reflecting the widespread anxiety among retail traders who chased the rally.

Meanwhile, the r/Shortsqueeze community highlighted the other side of the trade. A post noted that Moderna was 13% short when the price took off, and the potential loss for short sellers could exceed $3 billion. "The price is up $111 at the end of the day," the post read, underscoring the massive short squeeze that amplified the initial move.

On r/smallstreetbets, traders were already looking for the next play. A post titled "Is $SLS new $MRNA?" compared the setup of

SLS
$SLS to Moderna's recent surge, noting that SLS has upcoming Phase 3 AML data. "MRNA just printed +177% on cancer vaccine data. Cancer vaccines are back, baby!" the author wrote, suggesting SLS could replicate the move.

MRNA

The emotional whiplash in Reddit discussions captures the challenge of trading biotech stocks on binary catalysts. Moderna's cancer vaccine breakthrough is a genuine long-term story, but the violent price action — a 176% spike followed by a sharp pullback — reminds retail investors that even game-changing news can lead to painful volatility. With regulatory filings still ahead, the narrative is far from over.

Subscribe to Tendie.bot for more market recaps.